Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

Core Viewpoint - Catalyst Pharmaceuticals, Inc. is set to release its third quarter 2024 financial results on November 6, 2024, followed by a conference call on November 7, 2024, to discuss these results and provide a business update [1]. Company Overview - Catalyst Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing treatments for rare diseases, with a commitment to improving patient lives [2]. - The company has a proven track record of bringing innovative therapies to market and emphasizes accessibility through comprehensive support services [2]. - Catalyst is headquartered in Coral Gables, Florida, and has been recognized as one of America's most successful small-cap companies by Forbes in 2024 [2].